1. Home
  2. INSG vs HUMA Comparison

INSG vs HUMA Comparison

Compare INSG & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inseego Corp.

INSG

Inseego Corp.

HOLD

Current Price

$15.08

Market Cap

190.1M

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.71

Market Cap

155.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSG
HUMA
Founded
1996
2004
Country
United States
United States
Employees
N/A
184
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
190.1M
155.4M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
INSG
HUMA
Price
$15.08
$0.71
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$15.33
$6.19
AVG Volume (30 Days)
105.9K
5.7M
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$313,832,000.00
N/A
Revenue This Year
$16.21
$444.16
Revenue Next Year
$13.28
$248.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.28
$0.55
52 Week High
$18.08
$2.93

Technical Indicators

Market Signals
Indicator
INSG
HUMA
Relative Strength Index (RSI) 63.45 45.53
Support Level $10.74 $0.55
Resistance Level $16.88 $1.27
Average True Range (ATR) 0.77 0.06
MACD 0.13 0.02
Stochastic Oscillator 68.01 67.38

Price Performance

Historical Comparison
INSG
HUMA

About INSG Inseego Corp.

Inseego Corp is involved in the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things, and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by application software and cloud services designed to enable customers to analyze data insights and configure and manage their hardware easily. It generates maximum revenue from the United States and Canada. The company also has a presence in Europe (including the United Kingdom).

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: